EUVIMEDEUVIMED entdecken
Crossref

Feasibility and preliminary efficacy of behavioral activation for treatment of depression in autistic adolescents

Michelle Menezes iD, Christina Burroughs, Jessica Pappagianopoulos, Eleonora Sadikova, Emily Fuhrmann, Genevieve Bohac, Robert Cross, Lauren Witte, Gabrielle Brinkmann, Rachel Lemley, Denis G Sukhodolsky iD, Micah O Mazurek iD

Autism · 2024-12 · 28 (12) · 3021-3032

DOI: 10.1177/13623613241252470 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Autism, online erschienen am 19.05.2024. Verfasst von Michelle Menezes und 11 weiteren Autor:innen. Beteiligte Einrichtung: Yale School of Medicine, USA. Hauptthemen laut MEDLINE: Feasibility Studies, Depression, Behavior Therapy, Autistic Disorder. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: American Psychological Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Depression is common among autistic youth and is associated with worse quality of life in this group. Despite significant need for high-quality efficacious treatments, there has been very limited research on interventions for depression in autistic youth. This single-arm pilot study examined the feasibility and preliminary efficacy of a novel, behavior-based approach for treatment of depression symptoms in autistic adolescents without intellectual disability (i.e. Behavioral Activation for Autistic Adolescents, BA-A). BA-A is an individually delivered manualized 12-session treatment that utilizes established BA strategies and incorporates common mental health treatment adaptations for autistic young people. Of the 18 youth (11–16 years old) who enrolled, 15 completed all 12 treatment sessions, as well as pre-treatment, post-treatment, and follow-up assessment visits. Clinician treatment fidelity was quite high. Paired sample t-tests found that depression symptoms decreased pre- to post-BA-A according to multiple informants (i.e. self, caregiver, and independent evaluator), and treatment gains were maintained at 1-month follow-up. Paired sample t-tests also found that caregiver-reported anxiety symptoms and social skills improved pre-treatment to post-treatment. The results, although preliminary, indicate that BA-A may improve depression symptoms in autistic youth without intellectual disability. Furthermore, these promising findings suggest that a randomized controlled trial of BA-A is warranted. This trial was pre-registered at ClinicalTrials.gov (NCT05018169). Lay Abstract Depression is common among autistic youth and has a significant negative impact on quality of life and day-to-day functioning. Despite great need for efficacious treatments, there are currently limited research-supported interventions for depression symptoms in autistic young people. This study tested a novel, behavior-based approach or psychotherapy for treatment of depression symptoms in autistic adolescents without intellectual disability (i.e. Behavioral Activation for Autistic Adolescents, BA-A) with 15 youth (11–16 years old). BA-A is an individually delivered 12-session therapy that was developed for and to meet the needs of autistic youth with depression. Results found that autistic youth and their caregivers were able to participate in BA-A therapy sessions, and clinicians were able to deliver BA-A in accordance with the treatment manual. Notably, results demonstrated that autistic youth depression symptoms significantly improved after participating in BA-A. Furthermore, anxiety symptoms and social skills significantly improved following BA-A.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Feasibility StudiesDepressionBehavior TherapyAutistic DisorderHumansAdolescentMaleFemaleChildTreatment OutcomeSocial SkillsAnxietyAutism Spectrum Disorder

Stichwörter der Autor:innen

anxietyautism spectrum disordersdepressioninterventions—psychosocial/behavioralpsychiatric comorbidity

Autor:innen und Institutionen

  • Yale School of Medicine, USA.
  • Vanderbilt University Medical Center, USA.
  • University of Virginia, USA.

ORCID-Profile: Michelle Menezes, Denis G Sukhodolsky, Micah O Mazurek

Förderung

  • American Psychological Foundation

Zitieren

APA

Menezes, M., Burroughs, C., Pappagianopoulos, J., Sadikova, E., Fuhrmann, E., Bohac, G., Cross, R., Witte, L., Brinkmann, G., Lemley, R., Sukhodolsky, D. G., & Mazurek, M. O. (2024). Feasibility and preliminary efficacy of behavioral activation for treatment of depression in autistic adolescents. Autism, 28(12), 3021-3032. https://doi.org/10.1177/13623613241252470

Vancouver

Menezes M, Burroughs C, Pappagianopoulos J, Sadikova E, Fuhrmann E, Bohac G, et al. Feasibility and preliminary efficacy of behavioral activation for treatment of depression in autistic adolescents. Autism. 2024;28(12):3021-3032. doi:10.1177/13623613241252470

BibTeX
@article{Menezes2024,
  author = {Menezes, Michelle and Burroughs, Christina and Pappagianopoulos, Jessica and Sadikova, Eleonora and Fuhrmann, Emily and Bohac, Genevieve and Cross, Robert and Witte, Lauren and Brinkmann, Gabrielle and Lemley, Rachel and Sukhodolsky, Denis G and Mazurek, Micah O},
  title = {Feasibility and preliminary efficacy of behavioral activation for treatment of depression in autistic adolescents},
  journal = {Autism},
  year = {2024},
  volume = {28},
  number = {12},
  pages = {3021--3032},
  doi = {10.1177/13623613241252470}
}
Kostenlos starten →